Source: Annual Congress 2013 –COPD mechanisms
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Kochetova (Petrozavodsk, Russian Federation). To study the severity of lung hyperinflation and bone mineral density in patients with chronic obstructive pulmonary disease (COPD). Eur Respir J 2013; 42: Suppl. 57, 2150

Member's Comments

No comment yet.

Related content which might interest you: Frequency of osteoporosis and pulmonary diffusing capacity in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD: points to ponder Year: 2014 The decrease of nutritional status and increasing of the risk of osteoporotic fractures in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD biomarkers Year: 2013 The serum level of surfactantproteind in patients with chronic obstructive pulmonary disease, depending on the nutrtional status Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Pulmonary diffusing capacity and the risk of fractures in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD markers Year: 2014 Some gender features of the chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD treatment Year: 2013 Early phenotypes of chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Different data in COPD Year: 2015 Detection of chronic obstructive pulmonary disease (COPD) in patients with cardio-vascular system pathology Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Comparison of blood eosinophils and plasma periostin in stable and non-stable chronic obstructive pulmonary disease: How we can improve the management of our patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Factors associated with exacerbation in a general practitioners’-based Swiss chronic obstructive pulmonary disease (COPD) cohort Source: Annual Congress 2013 –The best posters in chronic care Year: 2013 FEV1 decline in patients with chronic obstructive pulmonary disease: Which treatment option is better for slowing of decline? Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015 The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Comparison of the effects of smoking and biomass exposure in chronic obstructive pulmonary disease Source: International Congress 2016 – Smoking-related diseases Year: 2016 Prevalence of vitamin D deficiency in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Lung volume response to bronchodilators is dependent on the stage of the disease in chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2006 - COPD therapy Year: 2006 Quality of life and disease burden of chronic obstructive pulmonary disease (COPD) patients in Northern Greece – The INCARE* study Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care Year: 2015 Benefits of pulmonary rehabilitation (PR) in patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) having the same dyspnoea severity Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? Year: 2018 Prevalence of chronic rhinosinusitis in COPD stable patients Source: Annual Congress 2006 - COPD comorbidity Year: 2006 The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013